GluN3A knockout mouse: Alternative model for Alzheimer's neurodegeneration

GluN3A-deficient mice display all aspects of Alzheimer's neurodegeneration.

from Women's Health News -- ScienceDaily https://ift.tt/3A8eBQo

GluN3A knockout mouse: Alternative model for Alzheimer's neurodegeneration

GluN3A-deficient mice display all aspects of Alzheimer's neurodegeneration.

from Women's Health News -- ScienceDaily https://ift.tt/3A8eBQo

Drug doubles down on bone cancer, metastasis

Researchers develop an antibody conjugate called BonTarg that delivers drugs to bone tumors and inhibits metastasis.

from Women's Health News -- ScienceDaily https://ift.tt/3daspzI

Drug doubles down on bone cancer, metastasis

Researchers develop an antibody conjugate called BonTarg that delivers drugs to bone tumors and inhibits metastasis.

from Breast Cancer News -- ScienceDaily https://ift.tt/3daspzI

Drug doubles down on bone cancer, metastasis

Researchers develop an antibody conjugate called BonTarg that delivers drugs to bone tumors and inhibits metastasis.

from Women's Health News -- ScienceDaily https://ift.tt/3daspzI

Fertility drugs do not increase breast cancer risk, study finds

Drugs routinely used during fertility treatments to release eggs do not increase the risk of developing breast cancer, new research has shown.

from Breast Cancer News -- ScienceDaily https://ift.tt/3xJT8uN

Fertility drugs do not increase breast cancer risk, study finds

Drugs routinely used during fertility treatments to release eggs do not increase the risk of developing breast cancer, new research has shown.

from Women's Health News -- ScienceDaily https://ift.tt/3xJT8uN

Fertility drugs do not increase breast cancer risk, study finds

Drugs routinely used during fertility treatments to release eggs do not increase the risk of developing breast cancer, new research has shown.

from Women's Health News -- ScienceDaily https://ift.tt/3xJT8uN

Some blood pressure-lowering meds linked to less memory decline in older adults, study finds

High blood pressure is a risk factor for cognitive decline and dementia in older adults. Studies have shown that commonly prescribed high blood pressure medications, or antihypertensives, may have a positive, beneficial impact on cognitive function including memory. This meta-analysis compares the impact on memory over time associated with taking antihypertensives that cross the blood-brain barrier versus those that do not.

from Women's Health News -- ScienceDaily https://ift.tt/3wM4xuc

Some blood pressure-lowering meds linked to less memory decline in older adults, study finds

High blood pressure is a risk factor for cognitive decline and dementia in older adults. Studies have shown that commonly prescribed high blood pressure medications, or antihypertensives, may have a positive, beneficial impact on cognitive function including memory. This meta-analysis compares the impact on memory over time associated with taking antihypertensives that cross the blood-brain barrier versus those that do not.

from Women's Health News -- ScienceDaily https://ift.tt/3wM4xuc

Does zinc inhibit or promote growth of kidney stones? Well, both

In the first study to validate conflicting theories, a researcher has confirmed that the zinc actually does inhibit and promote the growth of kidney stones at the same time.

from Women's Health News -- ScienceDaily https://ift.tt/3cGmPVH

Does zinc inhibit or promote growth of kidney stones? Well, both

In the first study to validate conflicting theories, a researcher has confirmed that the zinc actually does inhibit and promote the growth of kidney stones at the same time.

from Women's Health News -- ScienceDaily https://ift.tt/3cGmPVH

Cholesterol metabolite induces production of cancer-promoting vesicles

Scientists studying the link between cholesterol and breast cancer report that a byproduct of cholesterol metabolism causes some cells to send out cancer-promoting signals to other cells. These signals are packaged in membrane-bound compartments called extracellular vesicles.

from Breast Cancer News -- ScienceDaily https://ift.tt/3zfkPxq

New findings offer improved therapy of early-stage, BRCA mutation-associated breast cancer

A new treatment has potential to improve the outcomes for patients with hereditary BRCA mutations and high-risk, early-stage breast cancer. These results represent the first time a PARP inhibitor has been shown to significantly reduce the risk of breast cancer returning in high-risk patients following completion of standard chemotherapy, surgery and radiation therapy.

from Breast Cancer News -- ScienceDaily https://ift.tt/2Rp5PvL